{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T10:29:17Z","timestamp":1794565757796,"version":"4.9.1"},"reference-count":138,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T00:00:00Z","timestamp":1784246400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T00:00:00Z","timestamp":1787702400000},"content-version":"vor","delay-in-days":40,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100004440","name":"Wellcome Trust","doi-asserted-by":"publisher","award":["203249\/Z\/16\/Z"],"award-info":[{"award-number":["203249\/Z\/16\/Z"]}],"id":[{"id":"10.13039\/100004440","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000024","name":"Gouvernement du Canada | Canadian Institutes of Health Research","doi-asserted-by":"publisher","award":["406915"],"award-info":[{"award-number":["406915"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Mechanisms linking CD33 variants to Alzheimer Disease (AD) are poorly defined. Here, we combine structural, cellular, and genetic analyses to delineate how the CD33\n                    <jats:sup>M<\/jats:sup>\n                    splice isoform, upregulated in carriers of CD33 risk alleles, modulates microglial function. We show that CD33\n                    <jats:sup>M<\/jats:sup>\n                    ectodomain dimerizes, enabling binding of large multi-sialylated molecules. We demonstrate that another AD risk protein - clusterin (CLU)\u2009\u00b1\u2009A\u03b2 oligomers (but not ApoE) binds with nanomolar avidity to CD33\n                    <jats:sup>M<\/jats:sup>\n                    , but not CD33\n                    <jats:sup>m<\/jats:sup>\n                    . We show that in human monocytes CD33\n                    <jats:sup>M<\/jats:sup>\n                    :CLU binding induces CD33\n                    <jats:sup>M<\/jats:sup>\n                    ITIM phosphorylation, recruits SHP-1, suppresses A\u03b2 phagocytosis, and impairs clearance of amyloid plaques. We identify a soluble CD33\n                    <jats:sup>M<\/jats:sup>\n                    ectodomain fragment (sCD33\n                    <jats:sup>M<\/jats:sup>\n                    ) - absent from CD33\n                    <jats:sup>m<\/jats:sup>\n                    -expressing cells - which could contribute to the role of CD33\n                    <jats:sup>M<\/jats:sup>\n                    in AD. Genetic analyses confirm that CD33:CLU interaction modulates amyloid burden, cognition, and disease risk. These findings define a mechanistic CLU:A\u03b2:CD33\n                    <jats:sup>M<\/jats:sup>\n                    axis, highlighting CD33\n                    <jats:sup>M<\/jats:sup>\n                    dimerization and ligand-binding sites as potential therapeutic targets.\n                  <\/jats:p>","DOI":"10.1038\/s41467-026-75140-3","type":"journal-article","created":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T13:46:08Z","timestamp":1784295968000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["CD33 and clusterin interact biophysically and genetically to modulate Alzheimer risk"],"prefix":"10.1038","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4268-1863","authenticated-orcid":false,"given":"Roger B.","family":"Dodd","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masahiro","family":"Enomoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ye","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9684-239X","authenticated-orcid":false,"given":"Kanayo","family":"Satoh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yalun","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fusheng","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beatrice","family":"Acheson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5567-9581","authenticated-orcid":false,"given":"Deniz","family":"Ghaffari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-7497-3878","authenticated-orcid":false,"given":"Elizabeth","family":"Sayn-Wittgenstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6945-2254","authenticated-orcid":false,"given":"Jamie J.","family":"Manning","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-9738-9421","authenticated-orcid":false,"given":"George V.","family":"Dukas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ronak","family":"Patel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alondra Schweizer","family":"Burguete","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mason J.","family":"Kralovec","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mamunur","family":"Rashid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer L.","family":"Hall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7033-807X","authenticated-orcid":false,"given":"Kirstin A.","family":"Tamucci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4383-6305","authenticated-orcid":false,"given":"Zena","family":"Chatila","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minghua","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annie J.","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5560-4085","authenticated-orcid":false,"given":"Badri N.","family":"Vardarajan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariko F.","family":"Taga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7066-7052","authenticated-orcid":false,"given":"Sirkku","family":"Pollari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alon","family":"Rabinovich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cory D.","family":"Rillahan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrey A.","family":"Bobkov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eduard","family":"Sergienko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William","family":"Meadows","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seema","family":"Qamar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suzanne J.","family":"Randle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher M.","family":"Johnson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean","family":"Sevalle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Griffin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher","family":"Bohm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mitsuhiko","family":"Ikura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xunde","family":"Xian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8506-3400","authenticated-orcid":false,"given":"Joachim","family":"Herz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0877-126X","authenticated-orcid":false,"given":"Megan A.","family":"Kelly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8708-921X","authenticated-orcid":false,"given":"Jennifer","family":"West","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandeep","family":"Satapathy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9551-7445","authenticated-orcid":false,"given":"Mark R.","family":"Wilson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7395-2967","authenticated-orcid":false,"given":"Jonathan A.","family":"Javitch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1227-4239","authenticated-orcid":false,"given":"Paul E.","family":"Fraser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David A.","family":"Bennett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8057-2505","authenticated-orcid":false,"given":"Philip L.","family":"De Jager","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7097-6357","authenticated-orcid":false,"given":"Zvi","family":"Fishelson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dan","family":"Frenkel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7437-218X","authenticated-orcid":false,"given":"Wesley B.","family":"Asher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6766-4325","authenticated-orcid":false,"given":"Elizabeth M.","family":"Bradshaw","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0796-7209","authenticated-orcid":false,"given":"Peter St","family":"George-Hyslop","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,17]]},"reference":[{"key":"75140_CR1","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1002\/eji.200425273","volume":"35","author":"F Lajaunias","year":"2005","unstructured":"Lajaunias, F., Dayer, J. M. & Chizzolini, C. Constitutive repressor activity of CD33 on human monocytes requires sialic acid recognition and phosphoinositide 3-kinase-mediated intracellular signaling. Eur. J. Immunol. 35, 243\u2013251 (2005).","journal-title":"Eur. J. Immunol."},{"key":"75140_CR2","doi-asserted-by":"publisher","first-page":"11929","DOI":"10.1523\/JNEUROSCI.1860-14.2014","volume":"34","author":"Y Zhang","year":"2014","unstructured":"Zhang, Y. et al. An RNA-sequencing transcriptome and splicing database of glia, neurons, and vascular cells of the cerebral cortex. J. Neurosci. 34, 11929\u201311947 (2014).","journal-title":"J. Neurosci."},{"key":"75140_CR3","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1093\/glycob\/cwq220","volume":"21","author":"AB P\u00e9rez-Oliva","year":"2011","unstructured":"P\u00e9rez-Oliva, A. B. et al. Epitope mapping, expression and post-translational modifications of two isoforms of CD33 (CD33M and CD33m) on lymphoid and myeloid human cells. Glycobiology 21, 757\u2013770 (2011).","journal-title":"Glycobiology"},{"key":"75140_CR4","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1146\/annurev-immunol-102419-035900","volume":"38","author":"S Duan","year":"2020","unstructured":"Duan, S. & Paulson, J. C. Siglecs as immune cell checkpoints in disease. Annu Rev. Immunol. 38, 365\u2013395 (2020).","journal-title":"Annu Rev. Immunol."},{"key":"75140_CR5","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1038\/nri3737","volume":"14","author":"MS Macauley","year":"2014","unstructured":"Macauley, M. S., Crocker, P. R. & Paulson, J. C. Siglec-mediated regulation of immune cell function in disease. Nat. Rev. Immunol. 14, 653\u2013666 (2014).","journal-title":"Nat. Rev. Immunol."},{"key":"75140_CR6","doi-asserted-by":"publisher","first-page":"101111","DOI":"10.1016\/j.mam.2022.101111","volume":"90","author":"G Eskandari-Sedighi","year":"2022","unstructured":"Eskandari-Sedighi, G., Jung, J. & Macauley, M. S. CD33 isoforms in microglia and Alzheimer\u2019s disease: friend and foe. Mol. Asp. Med. 90, 101111 (2022).","journal-title":"Mol. Asp. Med."},{"key":"75140_CR7","doi-asserted-by":"publisher","first-page":"680","DOI":"10.1016\/j.jconrel.2021.09.010","volume":"338","author":"A Bhattacherjee","year":"2021","unstructured":"Bhattacherjee, A. et al. Increasing phagocytosis of microglia by targeting CD33 with liposomes displaying glycan ligands. J. Control Release 338, 680\u2013693 (2021).","journal-title":"J. Control Release"},{"key":"75140_CR8","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1186\/s13024-021-00443-6","volume":"16","author":"A Bhattacherjee","year":"2021","unstructured":"Bhattacherjee, A. et al. The CD33 short isoform is a gain-of-function variant that enhances Abeta(1-42) phagocytosis in microglia. Mol. Neurodegener. 16, 19 (2021).","journal-title":"Mol. Neurodegener."},{"key":"75140_CR9","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1111\/jnc.15349","volume":"158","author":"CA Butler","year":"2021","unstructured":"Butler, C. A., Thornton, P. & Brown, G. C. CD33M inhibits microglial phagocytosis, migration and proliferation, but the Alzheimer\u2019s disease-protective variant CD33m stimulates phagocytosis and proliferation, and inhibits adhesion. J. Neurochem 158, 297\u2013310 (2021).","journal-title":"J. Neurochem"},{"key":"75140_CR10","doi-asserted-by":"publisher","first-page":"1393","DOI":"10.1002\/glia.23968","volume":"69","author":"J Wissfeld","year":"2021","unstructured":"Wissfeld, J. et al. Deletion of Alzheimer\u2019s disease-associated CD33 results in an inflammatory human microglia phenotype. Glia 69, 1393\u20131412 (2021).","journal-title":"Glia"},{"key":"75140_CR11","doi-asserted-by":"publisher","first-page":"1556","DOI":"10.1038\/nn.4126","volume":"18","author":"G Chan","year":"2015","unstructured":"Chan, G. et al. CD33 modulates TREM2: convergence of Alzheimer loci. Nat. Neurosci. 18, 1556\u20131558 (2015).","journal-title":"Nat. Neurosci."},{"key":"75140_CR12","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1186\/s13024-022-00552-w","volume":"17","author":"JV Haure-Mirande","year":"2022","unstructured":"Haure-Mirande, J. V., Audrain, M., Ehrlich, M. E. & Gandy, S. Microglial TYROBP\/DAP12 in Alzheimer\u2019s disease: transduction of physiological and pathological signals across TREM2. Mol. Neurodegener. 17, 55 (2022).","journal-title":"Mol. Neurodegener."},{"key":"75140_CR13","doi-asserted-by":"publisher","first-page":"848","DOI":"10.1038\/nn.3435","volume":"16","author":"EM Bradshaw","year":"2013","unstructured":"Bradshaw, E. M. et al. CD33 Alzheimer\u2019s disease locus: altered monocyte function and amyloid biology. Nat. Neurosci. 16, 848\u2013850 (2013).","journal-title":"Nat. Neurosci."},{"key":"75140_CR14","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1016\/j.neuron.2013.04.014","volume":"78","author":"A Griciuc","year":"2013","unstructured":"Griciuc, A. et al. Alzheimer\u2019s disease risk gene CD33 inhibits microglial uptake of amyloid beta. Neuron 78, 631\u2013643 (2013).","journal-title":"Neuron"},{"key":"75140_CR15","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1189\/jlb.0205096","volume":"79","author":"T Hernandez-Caselles","year":"2006","unstructured":"Hernandez-Caselles, T. et al. A study of CD33 (SIGLEC-3) antigen expression and function on activated human T and NK cells: two isoforms of CD33 are generated by alternative splicing. J. Leukoc. Biol. 79, 46\u201358 (2006).","journal-title":"J. Leukoc. Biol."},{"key":"75140_CR16","doi-asserted-by":"publisher","first-page":"3372","DOI":"10.1074\/jbc.M210602200","volume":"278","author":"MS Alphey","year":"2003","unstructured":"Alphey, M. S., Attrill, H., Crocker, P. R. & van Aalten, D. M. High resolution crystal structures of Siglec-7: insights into ligand specificity in the Siglec family. J. Biol. Chem. 278, 3372\u20133377 (2003).","journal-title":"J. Biol. Chem."},{"key":"75140_CR17","doi-asserted-by":"publisher","first-page":"32774","DOI":"10.1074\/jbc.M601714200","volume":"281","author":"H Attrill","year":"2006","unstructured":"Attrill, H. et al. Siglec-7 undergoes a major conformational change when complexed with the alpha(2,8)-disialylganglioside GT1b. J. Biol. Chem. 281, 32774\u201332783 (2006).","journal-title":"J. Biol. Chem."},{"key":"75140_CR18","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1042\/BJ20060103","volume":"397","author":"H Attrill","year":"2006","unstructured":"Attrill, H. et al. The structure of siglec-7 in complex with sialosides: leads for rational structure-based inhibitor design. Biochem J. 397, 271\u2013278 (2006).","journal-title":"Biochem J."},{"key":"75140_CR19","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1016\/S1097-2765(00)80071-4","volume":"1","author":"AP May","year":"1998","unstructured":"May, A. P., Robinson, R. C., Vinson, M., Crocker, P. R. & Jones, E. Y. Crystal structure of the N-terminal domain of sialoadhesin in complex with 3\u2019 sialyllactose at 1.85 A resolution. Mol. Cell 1, 719\u2013728 (1998).","journal-title":"Mol. Cell"},{"key":"75140_CR20","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1016\/j.jmb.2007.10.009","volume":"375","author":"MA Zhuravleva","year":"2008","unstructured":"Zhuravleva, M. A., Trandem, K. & Sun, P. D. Structural implications of Siglec-5-mediated sialoglycan recognition. J. Mol. Biol. 375, 437\u2013447 (2008).","journal-title":"J. Mol. Biol."},{"key":"75140_CR21","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1038\/s41588-022-01024-z","volume":"54","author":"C Bellenguez","year":"2022","unstructured":"Bellenguez, C. et al. New insights into the genetic etiology of Alzheimer\u2019s disease and related dementias. Nat. Genet. 54, 412\u2013436 (2022).","journal-title":"Nat. Genet."},{"key":"75140_CR22","doi-asserted-by":"publisher","first-page":"461","DOI":"10.3233\/JAD-215055","volume":"86","author":"PP Kuksa","year":"2022","unstructured":"Kuksa, P. P. et al. Alzheimer\u2019s disease variant portal: a catalog of genetic findings for Alzheimer\u2019s disease. J. Alzheimers Dis. 86, 461\u2013477 (2022).","journal-title":"J. Alzheimers Dis."},{"key":"75140_CR23","first-page":"e12255","volume":"13","author":"D Xue","year":"2021","unstructured":"Xue, D. et al. Large-scale sequencing studies expand the known genetic architecture of Alzheimer\u2019s disease. Alzheimers Dement 13, e12255 (2021).","journal-title":"Alzheimers Dement"},{"key":"75140_CR24","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1001\/jamaneurol.2020.3536","volume":"78","author":"BW Kunkle","year":"2021","unstructured":"Kunkle, B. W. et al. Novel Alzheimer disease risk loci and pathways in African American individuals using the African genome resources panel: a meta-analysis. JAMA Neurol. 78, 102\u2013113 (2021).","journal-title":"JAMA Neurol."},{"key":"75140_CR25","doi-asserted-by":"publisher","first-page":"2561","DOI":"10.1093\/brain\/awaa209","volume":"143","author":"L Dumitrescu","year":"2020","unstructured":"Dumitrescu, L. et al. Genetic variants and functional pathways associated with resilience to Alzheimer\u2019s disease. Brain: a J. Neurol. 143, 2561\u20132575 (2020).","journal-title":"Brain: a J. Neurol."},{"key":"75140_CR26","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1038\/s41588-018-0311-9","volume":"51","author":"IE Jansen","year":"2019","unstructured":"Jansen, I. E. et al. Genome-wide meta-analysis identifies new loci and functional pathways influencing Alzheimer\u2019s disease risk. Nat. Genet. 51, 404\u2013413 (2019).","journal-title":"Nat. Genet."},{"key":"75140_CR27","doi-asserted-by":"publisher","first-page":"1452","DOI":"10.1038\/ng.2802","volume":"45","author":"JC Lambert","year":"2013","unstructured":"Lambert, J. C. et al. Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer\u2019s disease. Nat. Genet. 45, 1452\u20131458 (2013).","journal-title":"Nat. Genet."},{"key":"75140_CR28","doi-asserted-by":"publisher","first-page":"1373","DOI":"10.1038\/ng.3916","volume":"49","author":"R Sims","year":"2017","unstructured":"Sims, R. et al. Rare coding variants in PLCG2, ABI3, and TREM2 implicate microglial-mediated innate immunity in Alzheimer\u2019s disease. Nat. Genet. 49, 1373\u20131384 (2017).","journal-title":"Nat. Genet."},{"key":"75140_CR29","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1056\/NEJMoa1211851","volume":"368","author":"R Guerreiro","year":"2013","unstructured":"Guerreiro, R. et al. TREM2 variants in Alzheimer\u2019s disease.  N. Engl. J. Med. 368, 117\u2013127 (2013).","journal-title":"N. Engl. J. Med."},{"key":"75140_CR30","doi-asserted-by":"crossref","unstructured":"Schwartzentruber, J. et al. Genome-wide meta-analysis, fine-mapping and integrative prioritization implicate new Alzheimer's disease risk genes. Nat. Genet. 53, 392\u2013402 (2021).","DOI":"10.1038\/s41588-020-00776-w"},{"key":"75140_CR31","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-22491-8","volume":"12","author":"I de Rojas","year":"2021","unstructured":"de Rojas, I. et al. Common variants in Alzheimer\u2019s disease and risk stratification by polygenic risk scores. Nat. Commun. 12, 3417 (2021).","journal-title":"Nat. Commun."},{"key":"75140_CR32","doi-asserted-by":"publisher","first-page":"13320","DOI":"10.1523\/JNEUROSCI.1224-13.2013","volume":"33","author":"M Malik","year":"2013","unstructured":"Malik, M. et al. CD33 Alzheimer\u2019s risk-altering polymorphism, CD33 expression, and exon 2 splicing. J. Neurosci. 33, 13320\u201313325 (2013).","journal-title":"J. Neurosci."},{"key":"75140_CR33","doi-asserted-by":"publisher","first-page":"2729","DOI":"10.1093\/hmg\/ddt666","volume":"23","author":"T Raj","year":"2014","unstructured":"Raj, T. et al. CD33: increased inclusion of exon 2 implicates the Ig V-set domain in Alzheimer\u2019s disease susceptibility. Hum. Mol. Genet. 23, 2729\u20132736 (2014).","journal-title":"Hum. Mol. Genet."},{"key":"75140_CR34","doi-asserted-by":"publisher","first-page":"18803","DOI":"10.1074\/jbc.271.31.18803","volume":"271","author":"D Sgroi","year":"1996","unstructured":"Sgroi, D., Nocks, A. & Stamenkovic, I. A single N-linked glycosylation site is implicated in the regulation of ligand recognition by the I-type lectins CD22 and CD33. J. Biol. Chem. 271, 18803\u201318809 (1996).","journal-title":"J. Biol. Chem."},{"key":"75140_CR35","doi-asserted-by":"publisher","first-page":"1450","DOI":"10.1021\/acs.biochem.4c00864","volume":"64","author":"HN Vu","year":"2025","unstructured":"Vu, H. N., Situ, A. J., Dai, X. & Ulmer, T. S. Structure of the CD33 receptor and implications for the siglec family. Biochemistry 64, 1450\u20131462 (2025).","journal-title":"Biochemistry"},{"key":"75140_CR36","doi-asserted-by":"publisher","first-page":"2005","DOI":"10.1182\/blood.V85.8.2005.bloodjournal8582005","volume":"85","author":"S Freeman","year":"1995","unstructured":"Freeman, S., Kelm, S., Barber, E. & Crocker, P. Characterization of CD33 as a new member of the sialoadhesin family of cellular interaction molecules. Blood 85, 2005\u20132012 (1995).","journal-title":"Blood"},{"key":"75140_CR37","doi-asserted-by":"publisher","first-page":"31007","DOI":"10.1074\/jbc.M304331200","volume":"278","author":"O Blixt","year":"2003","unstructured":"Blixt, O., Collins, B. E., van den Nieuwenhof, I. M., Crocker, P. R. & Paulson, J. C. Sialoside specificity of the siglec family assessed using novel multivalent probes: identification of potent inhibitors of myelin-associated glycoprotein. J. Biol. Chem. 278, 31007\u201331019 (2003).","journal-title":"J. Biol. Chem."},{"key":"75140_CR38","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2105-13-334","volume":"13","author":"JM Duarte","year":"2012","unstructured":"Duarte, J. M., Srebniak, A., Scharer, M. A. & Capitani, G. Protein interface classification by evolutionary analysis. BMC Bioinforma. 13, 334 (2012).","journal-title":"BMC Bioinforma."},{"key":"75140_CR39","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1038\/nsmb.2479","volume":"20","author":"ES Rangarajan","year":"2013","unstructured":"Rangarajan, E. S. & Izard, T. Dimer asymmetry defines alpha-catenin interactions. Nat. Struct. Mol. Biol. 20, 188\u2013193 (2013).","journal-title":"Nat. Struct. Mol. Biol."},{"key":"75140_CR40","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.phrs.2014.06.001","volume":"87","author":"R Roskoski Jr.","year":"2014","unstructured":"Roskoski, R. Jr. ErbB\/HER protein-tyrosine kinases: structures and small molecule inhibitors. Pharm. Res. 87, 42\u201359 (2014).","journal-title":"Pharm. Res."},{"key":"75140_CR41","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1038\/s41592-021-01081-y","volume":"18","author":"WB Asher","year":"2021","unstructured":"Asher, W. B. et al. Single-molecule FRET imaging of GPCR dimers in living cells. Nat. Methods 18, 397\u2013405 (2021).","journal-title":"Nat. Methods"},{"key":"75140_CR42","doi-asserted-by":"publisher","first-page":"2287","DOI":"10.1080\/10428194.2019.1569232","volume":"60","author":"I Papageorgiou","year":"2019","unstructured":"Papageorgiou, I. et al. CCGG deletion (rs201074739) in CD33 results in premature termination codon and complete loss of CD33 expression: another key variant with potential impact on response to CD33-directed agents. Leuk. Lymphoma 60, 2287\u20132290 (2019).","journal-title":"Leuk. Lymphoma"},{"key":"75140_CR43","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1007\/s00401-019-02000-4","volume":"138","author":"S Estus","year":"2019","unstructured":"Estus, S. et al. Evaluation of CD33 as a genetic risk factor for Alzheimer\u2019s disease. Acta Neuropathol. 138, 187\u2013199 (2019).","journal-title":"Acta Neuropathol."},{"key":"75140_CR44","doi-asserted-by":"publisher","first-page":"a006270","DOI":"10.1101\/cshperspect.a006270","volume":"2","author":"C Haass","year":"2012","unstructured":"Haass, C., Kaether, C., Thinakaran, G. & Sisodia, S. Trafficking and proteolytic processing of APP. Cold Spring Harb. Perspect. Med. 2, a006270 (2012).","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"75140_CR45","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/j.conb.2021.09.003","volume":"72","author":"SF Lichtenthaler","year":"2022","unstructured":"Lichtenthaler, S. F., Tschirner, S. K. & Steiner, H. Secretases in Alzheimer\u2019s disease: novel insights into proteolysis of APP and TREM2. Curr. Opin. Neurobiol. 72, 101\u2013110 (2022).","journal-title":"Curr. Opin. Neurobiol."},{"key":"75140_CR46","doi-asserted-by":"publisher","first-page":"33027","DOI":"10.1074\/jbc.M113.517540","volume":"288","author":"P Wunderlich","year":"2013","unstructured":"Wunderlich, P. et al. Sequential proteolytic processing of the triggering receptor expressed on myeloid cells-2 (TREM2) protein by ectodomain shedding and \u03b3-secretase-dependent intramembranous cleavage. J. Biol. Chem. 288, 33027\u201333036 (2013).","journal-title":"J. Biol. Chem."},{"key":"75140_CR47","doi-asserted-by":"publisher","first-page":"1366","DOI":"10.15252\/emmm.201707673","volume":"9","author":"P Thornton","year":"2017","unstructured":"Thornton, P. et al. TREM2 shedding by cleavage at the H157-S158 bond is accelerated for the Alzheimer\u2019s disease-associated H157Y variant. EMBO Mol. Med. 9, 1366\u20131378 (2017).","journal-title":"EMBO Mol. Med."},{"key":"75140_CR48","doi-asserted-by":"publisher","first-page":"1356","DOI":"10.15252\/emmm.201707672","volume":"9","author":"K Schlepckow","year":"2017","unstructured":"Schlepckow, K. et al. An Alzheimer-associated TREM2 variant occurs at the ADAM cleavage site and affects shedding and phagocytic function. EMBO Mol. Med. 9, 1356\u20131365 (2017).","journal-title":"EMBO Mol. Med."},{"key":"75140_CR49","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1016\/j.neurobiolaging.2014.09.023","volume":"36","author":"DG Walker","year":"2015","unstructured":"Walker, D. G. et al. Association of CD33 polymorphism rs3865444 with Alzheimer\u2019s disease pathology and CD33 expression in human cerebral cortex. Neurobiol. Aging 36, 571\u2013582 (2015).","journal-title":"Neurobiol. Aging"},{"key":"75140_CR50","doi-asserted-by":"publisher","unstructured":"Bull, C. et al. Probing the binding specificities of human Siglecs by cell-based glycan arrays. Proc. Natl. Acad. Sci. USA. https:\/\/doi.org\/10.1073\/pnas.2026102118 (2021).","DOI":"10.1073\/pnas.2026102118"},{"key":"75140_CR51","doi-asserted-by":"publisher","first-page":"2673","DOI":"10.1021\/acschembio.1c00501","volume":"16","author":"J Jung","year":"2021","unstructured":"Jung, J. et al. Carbohydrate sulfation as a mechanism for fine-tuning Siglec ligands. ACS Chem. Biol. 16, 2673\u20132689 (2021).","journal-title":"ACS Chem. Biol."},{"key":"75140_CR52","doi-asserted-by":"publisher","unstructured":"Tsai, T. Y. et al. SIGLEC-3 (CD33) serves as an immune checkpoint receptor for HBV infection. J. Clin. Invest. https:\/\/doi.org\/10.1172\/JCI141965 (2021).","DOI":"10.1172\/JCI141965"},{"key":"75140_CR53","doi-asserted-by":"publisher","first-page":"101960","DOI":"10.1016\/j.jbc.2022.101960","volume":"298","author":"A Gonzalez-Gil","year":"2022","unstructured":"Gonzalez-Gil, A. et al. Human brain sialoglycan ligand for CD33, a microglial inhibitory Siglec implicated in Alzheimer\u2019s disease. J. Biol. Chem. 298, 101960 (2022).","journal-title":"J. Biol. Chem."},{"key":"75140_CR54","doi-asserted-by":"publisher","first-page":"2120","DOI":"10.1002\/pro.5560061007","volume":"6","author":"JT Kapron","year":"1997","unstructured":"Kapron, J. T. et al. Identification and characterization of glycosylation sites in human serum clusterin. Protein Sci. 6, 2120\u20132133 (1997).","journal-title":"Protein Sci."},{"key":"75140_CR55","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1186\/1750-1326-7-3","volume":"7","author":"K Bettens","year":"2012","unstructured":"Bettens, K. et al. Both common variations and rare non-synonymous substitutions and small insertion\/deletions in CLU are associated with increased Alzheimer risk. Mol. Neurodegener. 7, 3 (2012).","journal-title":"Mol. Neurodegener."},{"key":"75140_CR56","doi-asserted-by":"publisher","first-page":"1473","DOI":"10.1001\/archneurol.2010.201","volume":"67","author":"G Jun","year":"2010","unstructured":"Jun, G. et al. Meta-analysis confirms CR1, CLU, and PICALM as Alzheimer's disease risk loci and reveals interactions with APOE genotypes. Arch. Neurol. 67, 1473\u20131484 (2010).","journal-title":"Arch. Neurol."},{"key":"75140_CR57","doi-asserted-by":"publisher","first-page":"1094","DOI":"10.1038\/ng.439","volume":"41","author":"JC Lambert","year":"2009","unstructured":"Lambert, J. C. et al. Genome-wide association study identifies variants at CLU and CR1 associated with Alzheimer\u2019s disease. Nat. Genet. 41, 1094\u20131099 (2009).","journal-title":"Nat. Genet."},{"key":"75140_CR58","doi-asserted-by":"publisher","first-page":"1088","DOI":"10.1038\/ng.440","volume":"41","author":"D Harold","year":"2009","unstructured":"Harold, D. et al. Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer\u2019s disease. Nat. Genet. 41, 1088\u20131093 (2009).","journal-title":"Nat. Genet."},{"key":"75140_CR59","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1016\/j.neuron.2016.06.015","volume":"91","author":"FL Yeh","year":"2016","unstructured":"Yeh, F. L., Wang, Y., Tom, I., Gonzalez, L. C. & Sheng, M. TREM2 binds to apolipoproteins, including APOE and CLU\/APOJ, and thereby facilitates uptake of amyloid-beta by microglia. Neuron 91, 328\u2013340 (2016).","journal-title":"Neuron"},{"key":"75140_CR60","doi-asserted-by":"publisher","first-page":"15163","DOI":"10.1074\/jbc.M114.622209","volume":"290","author":"Y Hori","year":"2015","unstructured":"Hori, Y., Hashimoto, T., Nomoto, H., Hyman, B. T. & Iwatsubo, T. Role of apolipoprotein E in beta-amyloidogenesis: isoform-specific effects on protofibril to fibril conversion of abeta in vitro and brain abeta deposition in vivo. J. Biol. Chem. 290, 15163\u201315174 (2015).","journal-title":"J. Biol. Chem."},{"key":"75140_CR61","doi-asserted-by":"publisher","first-page":"6323","DOI":"10.1021\/bi5008172","volume":"53","author":"K Garai","year":"2014","unstructured":"Garai, K., Verghese, P. B., Baban, B., Holtzman, D. M. & Frieden, C. The binding of apolipoprotein E to oligomers and fibrils of amyloid-beta alters the kinetics of amyloid aggregation. Biochemistry 53, 6323\u20136331 (2014).","journal-title":"Biochemistry"},{"key":"75140_CR62","doi-asserted-by":"publisher","first-page":"a006312","DOI":"10.1101\/cshperspect.a006312","volume":"2","author":"DM Holtzman","year":"2012","unstructured":"Holtzman, D. M., Herz, J. & Bu, G. Apolipoprotein E and apolipoprotein E receptors: normal biology and roles in Alzheimer disease. Cold Spring Harb. Perspect. Med. 2, a006312 (2012).","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"75140_CR63","doi-asserted-by":"publisher","first-page":"1467","DOI":"10.1212\/WNL.43.8.1467","volume":"43","author":"AM Saunders","year":"1993","unstructured":"Saunders, A. M. et al. Association of apolipoprotein E allele epsilon 4 with late-onset familial and sporadic Alzheimer\u2019s disease. Neurology 43, 1467\u20131472 (1993).","journal-title":"Neurology"},{"key":"75140_CR64","doi-asserted-by":"crossref","unstructured":"Wilson, M. R., Yerbury, J. J. & Poon, S. In Heat Shock Proteins in the Brain: Implications for Neurodegenerative Diseases and Neuroprotection Vol. 3 (eds A. A. A. Asea & I. R. Brown) 283\u2013315 (Springer, 2008).","DOI":"10.1007\/978-1-4020-8231-3_15"},{"key":"75140_CR65","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1016\/S0896-6273(00)80861-2","volume":"24","author":"T Hiesberger","year":"1999","unstructured":"Hiesberger, T. et al. Direct binding of Reelin to VLDL receptor and ApoE receptor 2 induces tyrosine phosphorylation of disabled-1 and modulates tau phosphorylation. Neuron 24, 481\u2013489 (1999).","journal-title":"Neuron"},{"key":"75140_CR66","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1093\/glycob\/cwz084","volume":"30","author":"SA Flowers","year":"2020","unstructured":"Flowers, S. A., Grant, O. C., Woods, R. J. & Rebeck, G. W. O-glycosylation on cerebrospinal fluid and plasma apolipoprotein E differs in the lipid-binding domain. Glycobiology 30, 74\u201385 (2020).","journal-title":"Glycobiology"},{"key":"75140_CR67","doi-asserted-by":"publisher","first-page":"625348","DOI":"10.3389\/fnins.2020.625348","volume":"14","author":"H Haukedal","year":"2020","unstructured":"Haukedal, H. & Freude, K. K. Implications of glycosylation in Alzheimer\u2019s disease. Front Neurosci. 14, 625348 (2020).","journal-title":"Front Neurosci."},{"key":"75140_CR68","doi-asserted-by":"publisher","first-page":"105031","DOI":"10.1016\/j.isci.2022.105031","volume":"25","author":"SP Subramanian","year":"2022","unstructured":"Subramanian, S. P. & Gundry, R. L. The known unknowns of apolipoprotein glycosylation in health and disease. iScience 25, 105031 (2022).","journal-title":"iScience"},{"key":"75140_CR69","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1007\/978-1-4939-6598-4_18","volume":"1523","author":"A Bretteville","year":"2017","unstructured":"Bretteville, A., Demiautte, F. & Chapuis, J. Proximity ligation assay: a tool to study endogenous interactions between tau and its neuronal partners. Methods Mol. Biol. 1523, 297\u2013305 (2017).","journal-title":"Methods Mol. Biol."},{"key":"75140_CR70","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1007\/978-1-4939-3746-2_13","volume":"1447","author":"S Koch","year":"2016","unstructured":"Koch, S. et al. In situ proximity ligation assay (in situ PLA) to assess PTP-protein interactions. Methods Mol. Biol. 1447, 217\u2013242 (2016).","journal-title":"Methods Mol. Biol."},{"key":"75140_CR71","first-page":"19 28 11","volume":"85","author":"B Koos","year":"2016","unstructured":"Koos, B. & Soderberg, O. Designing and applying proximity-dependent hybridization chain reaction. Curr. Protoc. Protein Sci. 85, 19 28 11\u201319 28 13 (2016).","journal-title":"Curr. Protoc. Protein Sci."},{"key":"75140_CR72","doi-asserted-by":"publisher","unstructured":"Raykova, D. et al. Let there be light! Proteomes https:\/\/doi.org\/10.3390\/proteomes4040036 (2016).","DOI":"10.3390\/proteomes4040036"},{"key":"75140_CR73","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1038\/nsmb.2191","volume":"19","author":"P Narayan","year":"2011","unstructured":"Narayan, P. et al. The extracellular chaperone clusterin sequesters oligomeric forms of the amyloid-beta(1-40) peptide. Nat. Struct. Mol. Biol. 19, 79\u201383 (2011).","journal-title":"Nat. Struct. Mol. Biol."},{"key":"75140_CR74","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1002\/1097-0029(20000815)50:4<305::AID-JEMT10>3.0.CO;2-L","volume":"50","author":"M Calero","year":"2000","unstructured":"Calero, M. et al. Apolipoprotein J (clusterin) and Alzheimer\u2019s disease. Microsc Res Tech. 50, 305\u2013315 (2000).","journal-title":"Microsc Res Tech."},{"key":"75140_CR75","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1182\/blood.V96.2.483.014k40_483_490","volume":"96","author":"SP Paul","year":"2000","unstructured":"Paul, S. P., Taylor, L. S., Stansbury, E. K. & McVicar, D. W. Myeloid specific human CD33 is an inhibitory receptor with differential ITIM function in recruiting the phosphatases SHP-1 and SHP-2. Blood 96, 483\u2013490 (2000).","journal-title":"Blood"},{"key":"75140_CR76","doi-asserted-by":"publisher","first-page":"11505","DOI":"10.1074\/jbc.274.17.11505","volume":"274","author":"VC Taylor","year":"1999","unstructured":"Taylor, V. C. et al. The myeloid-specific sialic acid-binding receptor, CD33, associates with the protein-tyrosine phosphatases, SHP-1 and SHP-2. J. Biol. Chem. 274, 11505\u201311512 (1999).","journal-title":"J. Biol. Chem."},{"key":"75140_CR77","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1111\/j.1600-0854.2007.00682.x","volume":"9","author":"RB Walter","year":"2008","unstructured":"Walter, R. B. et al. Phosphorylated ITIMs enable ubiquitylation of an inhibitory cell surface receptor. Traffic 9, 267\u2013279 (2008).","journal-title":"Traffic"},{"key":"75140_CR78","doi-asserted-by":"publisher","first-page":"1204","DOI":"10.3390\/genes15091204","volume":"15","author":"L Beckers","year":"2024","unstructured":"Beckers, L. et al. CD33 and SHP-1\/PTPN6 interaction in Alzheimer\u2019s disease. Genes 15, 1204 (2024).","journal-title":"Genes"},{"key":"75140_CR79","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1093\/jb\/mvp001","volume":"145","author":"Y Tohyama","year":"2009","unstructured":"Tohyama, Y. & Yamamura, H. Protein tyrosine kinase, syk: a key player in phagocytic cells. J. Biochem. 145, 267\u2013273 (2009).","journal-title":"J. Biochem."},{"key":"75140_CR80","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-021-92434-2","volume":"11","author":"J Wi\u00dffeld","year":"2021","unstructured":"Wi\u00dffeld, J. et al. Reporter cell assay for human CD33 validated by specific antibodies and human iPSC-derived microglia. Sci. Rep. 11, 13462 (2021).","journal-title":"Sci. Rep."},{"key":"75140_CR81","doi-asserted-by":"publisher","first-page":"4135","DOI":"10.1016\/j.cell.2022.09.030","volume":"185","author":"H Ennerfelt","year":"2022","unstructured":"Ennerfelt, H. et al. SYK coordinates neuroprotective microglial responses in neurodegenerative disease. Cell 185, 4135\u20134152.e4122 (2022).","journal-title":"Cell"},{"key":"75140_CR82","doi-asserted-by":"publisher","first-page":"109920","DOI":"10.1016\/j.jneumeth.2023.109920","volume":"396","author":"M Marcatti","year":"2023","unstructured":"Marcatti, M. et al. A method to study human synaptic protein-protein interactions by using flow cytometry coupled to proximity ligation assay (Syn-FlowPLA. J. Neurosci. Methods 396, 109920 (2023).","journal-title":"J. Neurosci. Methods"},{"key":"75140_CR83","doi-asserted-by":"publisher","first-page":"9270","DOI":"10.1021\/bi301277k","volume":"51","author":"P Narayan","year":"2012","unstructured":"Narayan, P. et al. Amyloid-\u03b2 oligomers are sequestered by both intracellular and extracellular chaperones. Biochemistry 51, 9270\u20139276 (2012).","journal-title":"Biochemistry"},{"key":"75140_CR84","doi-asserted-by":"publisher","first-page":"10129","DOI":"10.1523\/JNEUROSCI.1202-06.2006","volume":"26","author":"H Oakley","year":"2006","unstructured":"Oakley, H. et al. Intraneuronal beta-amyloid aggregates, neurodegeneration, and neuron loss in transgenic mice with five familial Alzheimer\u2019s disease mutations: potential factors in amyloid plaque formation. J. Neurosci. 26, 10129\u201310140 (2006).","journal-title":"J. Neurosci."},{"key":"75140_CR85","doi-asserted-by":"publisher","first-page":"1443865","DOI":"10.3389\/fninf.2024.1443865","volume":"18","author":"AP P\u00e9rez-Gonz\u00e1lez","year":"2024","unstructured":"P\u00e9rez-Gonz\u00e1lez, A. P. et al. The ROSMAP project: aging and neurodegenerative diseases through omic sciences. Front Neuroinform 18, 1443865 (2024).","journal-title":"Front Neuroinform"},{"key":"75140_CR86","doi-asserted-by":"publisher","first-page":"634","DOI":"10.1038\/s41586-024-07871-6","volume":"633","author":"GS Green","year":"2024","unstructured":"Green, G. S. et al. Cellular communities reveal trajectories of brain ageing and Alzheimer\u2019s disease. Nature 633, 634\u2013645 (2024).","journal-title":"Nature"},{"key":"75140_CR87","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1016\/j.bj.2019.07.010","volume":"42","author":"JR Enterina","year":"2019","unstructured":"Enterina, J. R., Jung, J. & Macauley, M. S. Coordinated roles for glycans in regulating the inhibitory function of CD22 on B cells. Biomed. J. 42, 218\u2013232 (2019).","journal-title":"Biomed. J."},{"key":"75140_CR88","doi-asserted-by":"publisher","first-page":"15312","DOI":"10.1074\/jbc.M117.799346","volume":"292","author":"SS Siddiqui","year":"2017","unstructured":"Siddiqui, S. S. et al. The Alzheimer\u2019s disease-protective CD33 splice variant mediates adaptive loss of function via diversion to an intracellular pool. J. Biol. Chem. 292, 15312\u201315320 (2017).","journal-title":"J. Biol. Chem."},{"key":"75140_CR89","doi-asserted-by":"publisher","unstructured":"Pohlkamp, T. et al. NHE6 depletion corrects ApoE4-mediated synaptic impairments and reduces amyloid plaque load. Elife https:\/\/doi.org\/10.7554\/eLife.72034 (2021).","DOI":"10.7554\/eLife.72034"},{"key":"75140_CR90","doi-asserted-by":"publisher","first-page":"6875","DOI":"10.1074\/jbc.274.11.6875","volume":"274","author":"DT Humphreys","year":"1999","unstructured":"Humphreys, D. T., Carver, J. A., Easterbrook-Smith, S. B. & Wilson, M. R. Clusterin has chaperone-like activity similar to that of small heat shock proteins. J. Biol. Chem. 274, 6875\u20136881 (1999).","journal-title":"J. Biol. Chem."},{"key":"75140_CR91","doi-asserted-by":"publisher","first-page":"1925","DOI":"10.1016\/j.neuron.2025.03.034","volume":"113","author":"AM Lish","year":"2025","unstructured":"Lish, A. M. et al. CLU alleviates Alzheimer\u2019s disease-relevant processes by modulating astrocyte reactivity and microglia-dependent synaptic density. Neuron 113, 1925\u20131946 e1911 (2025).","journal-title":"Neuron"},{"key":"75140_CR92","doi-asserted-by":"publisher","unstructured":"Xian, X. et al. Reversal of ApoE4 induced recycling block as a novel prevention approach for Alzheimer\u2019s disease. Elife https:\/\/doi.org\/10.7554\/eLife.40048 (2018).","DOI":"10.7554\/eLife.40048"},{"key":"75140_CR93","doi-asserted-by":"publisher","first-page":"2035","DOI":"10.1038\/s41594-025-01631-4","volume":"32","author":"P Yuste-Checa","year":"2025","unstructured":"Yuste-Checa, P. et al. Structural analyses define the molecular basis of clusterin chaperone function. Nat. Struct. Mol. Biol. 32, 2035\u20132045 (2025).","journal-title":"Nat. Struct. Mol. Biol."},{"key":"75140_CR94","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/j.blre.2014.04.001","volume":"28","author":"GS Laszlo","year":"2014","unstructured":"Laszlo, G. S., Estey, E. H. & Walter, R. B. The past and future of CD33 as therapeutic target in acute myeloid leukemia. Blood Rev. 28, 143\u2013153 (2014).","journal-title":"Blood Rev."},{"key":"75140_CR95","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1080\/13543784.2018.1452911","volume":"27","author":"RB Walter","year":"2018","unstructured":"Walter, R. B. Investigational CD33-targeted therapeutics for acute myeloid leukemia. Expert Opin. Investig. Drugs 27, 339\u2013348 (2018).","journal-title":"Expert Opin. Investig. Drugs"},{"key":"75140_CR96","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.exphem.2017.06.007","volume":"54","author":"AA Laing","year":"2017","unstructured":"Laing, A. A., Harrison, C. J., Gibson, B. E. S. & Keeshan, K. Unlocking the potential of anti-CD33 therapy in adult and childhood acute myeloid leukemia. Exp. Hematol. 54, 40\u201350 (2017).","journal-title":"Exp. Hematol."},{"key":"75140_CR97","doi-asserted-by":"publisher","first-page":"1710","DOI":"10.1002\/glia.22988","volume":"64","author":"PD Wes","year":"2016","unstructured":"Wes, P. D., Sayed, F. A., Bard, F. & Gan, L. Targeting microglia for the treatment of Alzheimer\u2019s Disease. Glia 64, 1710\u20131732 (2016).","journal-title":"Glia"},{"key":"75140_CR98","doi-asserted-by":"publisher","unstructured":"Greenberg, S. M., Bax, F. & van Veluw, S. J. Amyloid-related imaging abnormalities: manifestations, metrics and mechanisms. Nat. Rev. Neurol. https:\/\/doi.org\/10.1038\/s41582-024-01053-8 (2025).","DOI":"10.1038\/s41582-024-01053-8"},{"key":"75140_CR99","doi-asserted-by":"publisher","first-page":"1243","DOI":"10.1107\/S0907444906029799","volume":"62","author":"AR Aricescu","year":"2006","unstructured":"Aricescu, A. R., Lu, W. & Jones, E. Y. A time- and cost-efficient system for high-level protein production in mammalian cells. Acta Crystallogr. D. Biol. Crystallogr. 62, 1243\u20131250 (2006).","journal-title":"Acta Crystallogr. D. Biol. Crystallogr."},{"key":"75140_CR100","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1002\/bit.21596","volume":"99","author":"G Backliwal","year":"2008","unstructured":"Backliwal, G., Hildinger, M., Hasija, V. & Wurm, F. M. High-density transfection with HEK-293 cells allows doubling of transient titers and removes need for a priori DNA complex formation with PEI. Biotechnol. Bioeng. 99, 721\u2013727 (2008).","journal-title":"Biotechnol. Bioeng."},{"key":"75140_CR101","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1016\/j.jbiotec.2010.05.003","volume":"148","author":"S Wulhfard","year":"2010","unstructured":"Wulhfard, S., Baldi, L., Hacker, D. L. & Wurm, F. Valproic acid enhances recombinant mRNA and protein levels in transiently transfected Chinese hamster ovary cells. J. Biotechnol. 148, 128\u2013132 (2010).","journal-title":"J. Biotechnol."},{"key":"75140_CR102","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1016\/0167-4838(92)90062-I","volume":"1159","author":"MR Wilson","year":"1992","unstructured":"Wilson, M. R. & Easterbrook-Smith, S. B. Clusterin binds by a multivalent mechanism to the Fc and Fab regions of IgG. Biochim. Biophys. Acta 1159, 319\u2013326 (1992).","journal-title":"Biochim. Biophys. Acta"},{"key":"75140_CR103","doi-asserted-by":"publisher","first-page":"1260","DOI":"10.1107\/S0907444913015308","volume":"69","author":"G Winter","year":"2013","unstructured":"Winter, G., Lobley, C. M. & Prince, S. M. Decision making in xia2. Acta Crystallogr. D. Biol. Crystallogr. 69, 1260\u20131273 (2013).","journal-title":"Acta Crystallogr. D. Biol. Crystallogr."},{"key":"75140_CR104","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1107\/S0907444909047337","volume":"66","author":"W Kabsch","year":"2010","unstructured":"Kabsch, W. Xds. Acta Crystallogr D. Biol. Crystallogr 66, 125\u2013132 (2010).","journal-title":"Acta Crystallogr D. Biol. Crystallogr"},{"key":"75140_CR105","doi-asserted-by":"publisher","first-page":"1579","DOI":"10.1107\/S1399004714005550","volume":"70","author":"CX Weichenberger","year":"2014","unstructured":"Weichenberger, C. X. & Rupp, B. Ten years of probabilistic estimates of biocrystal solvent content: new insights via nonparametric kernel density estimate. Acta Crystallogr. D. Biol. Crystallogr. 70, 1579\u20131588 (2014).","journal-title":"Acta Crystallogr. D. Biol. Crystallogr."},{"key":"75140_CR106","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1107\/S0021889807021206","volume":"40","author":"AJ McCoy","year":"2007","unstructured":"McCoy, A. J. et al. Phaser crystallographic software. J. Appl. Crystallogr 40, 658\u2013674 (2007).","journal-title":"J. Appl. Crystallogr"},{"key":"75140_CR107","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1107\/S0907444910051218","volume":"67","author":"G Bunkoczi","year":"2011","unstructured":"Bunkoczi, G. & Read, R. J. Improvement of molecular-replacement models with Sculptor. Acta Crystallogr. D. Biol. Crystallogr. 67, 303\u2013312 (2011).","journal-title":"Acta Crystallogr. D. Biol. Crystallogr."},{"key":"75140_CR108","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1107\/S090744490705024X","volume":"64","author":"TC Terwilliger","year":"2008","unstructured":"Terwilliger, T. C. et al. Iterative model building, structure refinement and density modification with the PHENIX AutoBuild wizard. Acta Crystallogr. D. Biol. Crystallogr. 64, 61\u201369 (2008).","journal-title":"Acta Crystallogr. D. Biol. Crystallogr."},{"key":"75140_CR109","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1107\/S0907444909052925","volume":"66","author":"PD Adams","year":"2010","unstructured":"Adams, P. D. et al. PHENIX: a comprehensive Python-based system for macromolecular structure solution. Acta Crystallogr. D. Biol. Crystallogr. 66, 213\u2013221 (2010).","journal-title":"Acta Crystallogr. D. Biol. Crystallogr."},{"key":"75140_CR110","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1107\/S0907444912001308","volume":"68","author":"PV Afonine","year":"2012","unstructured":"Afonine, P. V. et al. Towards automated crystallographic structure refinement with phenix.refine. Acta Crystallogr. D. Biol. Crystallogr. 68, 352\u2013367 (2012).","journal-title":"Acta Crystallogr. D. Biol. Crystallogr."},{"key":"75140_CR111","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1107\/S0907444910007493","volume":"66","author":"P Emsley","year":"2010","unstructured":"Emsley, P., Lohkamp, B., Scott, W. G. & Cowtan, K. Features and development of Coot. Acta Crystallogr. D. Biol. Crystallogr. 66, 486\u2013501 (2010).","journal-title":"Acta Crystallogr. D. Biol. Crystallogr."},{"key":"75140_CR112","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1107\/S1399004714028132","volume":"71","author":"PV Afonine","year":"2015","unstructured":"Afonine, P. V. et al. FEM: feature-enhanced map. Acta Crystallogr. D. Biol. Crystallogr. 71, 646\u2013666 (2015).","journal-title":"Acta Crystallogr. D. Biol. Crystallogr."},{"key":"75140_CR113","unstructured":"Schrodinger, L. L. C. The PyMOL Molecular Graphics System, Version 1.7.4 (2015)."},{"key":"75140_CR114","doi-asserted-by":"publisher","first-page":"2309","DOI":"10.1016\/j.bpj.2011.03.004","volume":"100","author":"H Zhao","year":"2011","unstructured":"Zhao, H., Brown, P. H. & Schuck, P. On the distribution of protein refractive index increments. Biophys. J. 100, 2309\u20132317 (2011).","journal-title":"Biophys. J."},{"key":"75140_CR115","unstructured":"Theisen, A., Johann, C., Deacon, M. P. & Harding, S. E. Refractive Increment Data-Book for Polymer and Biomolecular Scientists (Nottingham University Press, 2000)."},{"key":"75140_CR116","doi-asserted-by":"publisher","first-page":"12011","DOI":"10.1073\/pnas.0914984107","volume":"107","author":"Y Chen","year":"2010","unstructured":"Chen, Y., Durakoglugil, M. S., Xian, X. & Herz, J. ApoE4 reduces glutamate receptor function and synaptic plasticity by selectively impairing ApoE receptor recycling. Proc. Natl. Acad. Sci. USA 107, 12011\u201312016 (2010).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"75140_CR117","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1038\/nmeth.1774","volume":"9","author":"RB Altman","year":"2011","unstructured":"Altman, R. B. et al. Cyanine fluorophore derivatives with enhanced photostability. Nat. Methods 9, 68\u201371 (2011).","journal-title":"Nat. Methods"},{"key":"75140_CR118","doi-asserted-by":"publisher","first-page":"1351","DOI":"10.1126\/science.1900642","volume":"251","author":"S O\u2019Gorman","year":"1991","unstructured":"O\u2019Gorman, S., Fox, D. T. & Wahl, G. M. Recombinase-mediated gene activation and site-specific integration in mammalian cells. Science 251, 1351\u20131355 (1991).","journal-title":"Science"},{"key":"75140_CR119","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1039\/C6SC02976K","volume":"8","author":"Q Zheng","year":"2017","unstructured":"Zheng, Q. et al. Electronic tuning of self-healing fluorophores for live-cell and single-molecule imaging. Chem. Sci. 8, 755\u2013762 (2017).","journal-title":"Chem. Sci."},{"key":"75140_CR120","doi-asserted-by":"publisher","first-page":"24305","DOI":"10.1073\/pnas.2006517117","volume":"117","author":"AK Pati","year":"2020","unstructured":"Pati, A. K. et al. Tuning the Baird aromatic triplet-state energy of cyclooctatetraene to maximize the self-healing mechanism in organic fluorophores. Proc. Natl. Acad. Sci. USA. 117, 24305\u201324315 (2020).","journal-title":"Proc. Natl. Acad. Sci. USA."},{"key":"75140_CR121","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1016\/j.ymeth.2016.09.016","volume":"115","author":"JY Tinevez","year":"2017","unstructured":"Tinevez, J. Y. et al. TrackMate: An open and extensible platform for single-particle tracking. Methods 115, 80\u201390 (2017).","journal-title":"Methods"},{"key":"75140_CR122","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1038\/nmeth.2089","volume":"9","author":"CA Schneider","year":"2012","unstructured":"Schneider, C. A., Rasband, W. S. & Eliceiri, K. W. NIH Image to ImageJ: 25 years of image analysis. Nat. Methods 9, 671\u2013675 (2012).","journal-title":"Nat. Methods"},{"key":"75140_CR123","doi-asserted-by":"publisher","first-page":"1018","DOI":"10.1016\/j.bpj.2018.01.012","volume":"114","author":"AR Vega","year":"2018","unstructured":"Vega, A. R., Freeman, S. A., Grinstein, S. & Jaqaman, K. Multistep track segmentation and motion classification for transient mobility analysis. Biophys. J. 114, 1018\u20131025 (2018).","journal-title":"Biophys. J."},{"key":"75140_CR124","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1038\/nmeth.1237","volume":"5","author":"K Jaqaman","year":"2008","unstructured":"Jaqaman, K. et al. Robust single-particle tracking in live-cell time-lapse sequences. Nat. Methods 5, 695\u2013702 (2008).","journal-title":"Nat. Methods"},{"key":"75140_CR125","doi-asserted-by":"publisher","first-page":"101926","DOI":"10.1016\/j.scr.2020.101926","volume":"47","author":"A Patel","year":"2020","unstructured":"Patel, A., Garcia Diaz, A., Moore, J. C., Sirabella, D. & Corneo, B. Establishment and characterization of two iPSC lines derived from healthy controls. Stem Cell Res. 47, 101926 (2020).","journal-title":"Stem Cell Res."},{"key":"75140_CR126","doi-asserted-by":"crossref","unstructured":"Patel, R. et al. Reduced SH3RF3 May Protect Against Alzheimer's Disease by Lowering Microglial Pro-Inflammatory Responses via Modulation of JNK and NFkB Signaling. Glia. 74, e70165 (2026).","DOI":"10.1002\/glia.70165"},{"key":"75140_CR127","doi-asserted-by":"publisher","DOI":"10.1186\/s13024-018-0297-x","volume":"13","author":"A McQuade","year":"2018","unstructured":"McQuade, A. et al. Development and validation of a simplified method to generate human microglia from pluripotent stem cells. Mol. Neurodegener. 13, 67 (2018).","journal-title":"Mol. Neurodegener."},{"key":"75140_CR128","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1016\/j.neuron.2017.03.042","volume":"94","author":"EM Abud","year":"2017","unstructured":"Abud, E. M. et al. iPSC-derived human microglia-like cells to study neurological diseases. Neuron 94, 278\u2013293.e279 (2017).","journal-title":"Neuron"},{"key":"75140_CR129","doi-asserted-by":"publisher","DOI":"10.1038\/sdata.2018.142","volume":"5","author":"PL De Jager","year":"2018","unstructured":"De Jager, P. L. et al. A multi-omic atlas of the human frontal cortex for aging and Alzheimer\u2019s disease research. Sci. Data 5, 180142 (2018).","journal-title":"Sci. Data"},{"key":"75140_CR130","doi-asserted-by":"publisher","first-page":"1418","DOI":"10.1038\/nn.4632","volume":"20","author":"B Ng","year":"2017","unstructured":"Ng, B. et al. An xQTL map integrates the genetic architecture of the human brain\u2019s transcriptome and epigenome. Nat. Neurosci. 20, 1418\u20131426 (2017).","journal-title":"Nat. Neurosci."},{"key":"75140_CR131","doi-asserted-by":"publisher","first-page":"S161","DOI":"10.3233\/JAD-179939","volume":"64","author":"DA Bennett","year":"2018","unstructured":"Bennett, D. A. et al. Religious orders study and rush memory and aging project. J. Alzheimers Dis. 64, S161\u2013S189 (2018).","journal-title":"J. Alzheimers Dis."},{"key":"75140_CR132","doi-asserted-by":"publisher","first-page":"1837","DOI":"10.1212\/01.wnl.0000219668.47116.e6","volume":"66","author":"DA Bennett","year":"2006","unstructured":"Bennett, D. A. et al. Neuropathology of older persons without cognitive impairment from two community-based studies. Neurology 66, 1837\u20131844 (2006).","journal-title":"Neurology"},{"key":"75140_CR133","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1212\/WNL.59.2.198","volume":"59","author":"DA Bennett","year":"2002","unstructured":"Bennett, D. A. et al. Natural history of mild cognitive impairment in older persons. Neurology 59, 198\u2013205 (2002).","journal-title":"Neurology"},{"key":"75140_CR134","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1159\/000096129","volume":"27","author":"DA Bennett","year":"2006","unstructured":"Bennett, D. A. et al. Decision rules guiding the clinical diagnosis of Alzheimer\u2019s disease in two community-based cohort studies compared to standard practice in a clinic-based cohort study. Neuroepidemiology 27, 169\u2013176 (2006).","journal-title":"Neuroepidemiology"},{"key":"75140_CR135","doi-asserted-by":"publisher","first-page":"e1474","DOI":"10.1212\/WNL.0000000000206833","volume":"100","author":"S Oveisgharan","year":"2023","unstructured":"Oveisgharan, S. et al. Estrogen receptor genes, cognitive decline, and Alzheimer disease. Neurology 100, e1474\u2013e1487 (2023).","journal-title":"Neurology"},{"key":"75140_CR136","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1002\/ana.25380","volume":"85","author":"PA Boyle","year":"2019","unstructured":"Boyle, P. A. et al. Attributable risk of Alzheimer\u2019s dementia attributed to age-related neuropathologies. Ann. Neurol. 85, 114\u2013124 (2019).","journal-title":"Ann. Neurol."},{"key":"75140_CR137","doi-asserted-by":"publisher","first-page":"2166","DOI":"10.1093\/brain\/awab092","volume":"144","author":"PA Boyle","year":"2021","unstructured":"Boyle, P. A. et al. To what degree is late life cognitive decline driven by age-related neuropathologies. Brain 144, 2166\u20132175 (2021).","journal-title":"Brain"},{"key":"75140_CR138","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1107\/S0907444909042073","volume":"66","author":"VB Chen","year":"2010","unstructured":"Chen, V. B. et al. MolProbity: all-atom structure validation for macromolecular crystallography. Acta Crystallogr. D. Biol. Crystallogr. 66, 12\u201321 (2010).","journal-title":"Acta Crystallogr. D. Biol. Crystallogr."}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-75140-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-75140-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-75140-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T00:02:12Z","timestamp":1787702532000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-75140-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,17]]},"references-count":138,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["75140"],"URL":"https:\/\/doi.org\/10.1038\/s41467-026-75140-3","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,17]]},"assertion":[{"value":"17 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}}],"article-number":"8983"}}